<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0864-0300</journal-id>
<journal-title><![CDATA[Revista Cubana de Investigaciones Biomédicas]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Cubana Invest Bioméd]]></abbrev-journal-title>
<issn>0864-0300</issn>
<publisher>
<publisher-name><![CDATA[ECIMED]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0864-03002004000100004</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Algunos factores clínicos de riesgo cardiovascular en un grupo de diabéticos del municipio Artemisa]]></article-title>
<article-title xml:lang="en"><![CDATA[Some clinical factors of cardiovascular risk in a group of diabetic patients from Artemisa municipality]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Guzmán]]></surname>
<given-names><![CDATA[Mayque]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pérez Chil]]></surname>
<given-names><![CDATA[Juan Carlos]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Casanueva Cabeza]]></surname>
<given-names><![CDATA[Manuel Francisco]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Barreto Cruz]]></surname>
<given-names><![CDATA[Tamara]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,Hospital General  ]]></institution>
<addr-line><![CDATA[La Habana ]]></addr-line>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>03</month>
<year>2004</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>03</month>
<year>2004</year>
</pub-date>
<volume>23</volume>
<numero>1</numero>
<fpage>23</fpage>
<lpage>30</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S0864-03002004000100004&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S0864-03002004000100004&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S0864-03002004000100004&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Se realizó un estudio transversal descriptivo que incluyó los 457 diabéticos, de 30 consultorios médicos del municipio Artemisa. Fueron encuestados y examinados 419 (91,6 %). La prevalencia resultó en 2,25 %. El sexo femenino predominó (70,88 %) al igual que el tipo 2 de diabetes. La edad media excedió los 60 años en uno y otro sexos. El hábito de fumar fue más frecuente en el sexo masculino. El sedentarismo superó 50 % en los 2 sexos. La prevalencia de hipertensión arterial fue de 68,66 % (70,27 % en mujeres y 64,75 % en hombres). Se detectaron cifras elevadas de tensión arterial en 65,19 % de las mujeres hipertensas conocidas y en 69,69 % de los hombres, que seguían algún tipo de tratamiento antihipertensivo. En 9,56 % de los pacientes se detectaron cifras anormales de tensión arterial, sin diagnóstico ni tratamiento antihipertensivo previos. Más de 60 % de los pacientes cumplían los criterios de sobrepeso y obesidad (índice de masa corporal > 25 kg/ m²). Se encontraron cifras de índice cintura/cadera de riesgo en 88,47 % de las mujeres y en 81,15 % de los hombres. Evidentemente el sedentarismo, la obesidad y la hipertensión arterial son fenómenos que afectan con frecuencia a los diabéticos. Se deben establecer estrategias que promuevan cambios en el estilo de vida de este grupo de pacientes]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[A cross-sectional descriptive study was conducted among 457 diabetic patients from 30 family physicians' offices of Artemisa municipality. 419 (91.6 %) were surveyed and examined. There was a prevalence of 2.25 %. Females (70.88 %) and type 2 diabetes predominated. The average age was over 60 in both sexes. Smoking was more frequent in males. Sedentarism exceeded 50 % in both sexes. The prevalence of arterial hypertension was 68.66 % (70.27 % in females and 64.75 % in males). High readings of arterial hypertension were detected in 65.19 % of known hypertensive females and in 69.9 % of men that were under some type of antihypertensive treatment. Abnormal readings of arterial pressure were observed in 9.56 % of the patients with no previous diagnosis, or antihypertenvie treatment. More than 60 % of the patients fulfilled the overweight and obesity criteria (body mass index >25 kg/m2). Figures of waist/hip risk index were found in 88.47 % of females and in 81.15 % of males. Obviously, sedentarism, obesity and arterial hypertension are phenomena frequently affecting the diabetic patients. Strategies should be established to promote changes in the lifestyle of this group of patients.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[DIABETES MELLITUS]]></kwd>
<kwd lng="es"><![CDATA[DIABETES MELLITUS]]></kwd>
<kwd lng="es"><![CDATA[FACTORES DE RIESGO]]></kwd>
<kwd lng="es"><![CDATA[HIPERTENSION]]></kwd>
<kwd lng="es"><![CDATA[OBESIDAD]]></kwd>
<kwd lng="es"><![CDATA[TABAQUISMO]]></kwd>
<kwd lng="en"><![CDATA[DIABETES MELLITUS]]></kwd>
<kwd lng="en"><![CDATA[DIABETES MELLITUS]]></kwd>
<kwd lng="en"><![CDATA[RISK FACTORS]]></kwd>
<kwd lng="en"><![CDATA[HYPERTENSION]]></kwd>
<kwd lng="en"><![CDATA[OBESITY]]></kwd>
<kwd lng="en"><![CDATA[SMOKING]]></kwd>
</kwd-group>
</article-meta>
</front><body><![CDATA[ <div class=Section1>    <p class=MsoNormal><span style='font-size:11.0pt;mso-bidi-font-size:10.0pt; font-family:"CG Times"'>Hospital General “Ciro Redondo García”    <br> </span><span lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt; font-family:"CG Times";mso-ansi-language:ES-MX;mso-bidi-font-weight:bold'>Instituto  Superior de Ciencias Médicas de La Habana</span></p>    <p class=MsoNormal><b style='mso-bidi-font-weight:normal'><span lang=ES-MX style='font-size:14.0pt;mso-bidi-font-size:10.0pt;font-family:Arial;mso-ansi-language: ES-MX'>Algunos factores clínicos de riesgo cardiovascular en un grupo de diabéticos  del municipio Artemisa</span></b></p>    <p class=MsoNormal style='text-align:justify'>Dr.  Mayque Guzmán, Dr. Juan Carlos Pérez Chil, Dr. Manuel Francisco Casanueva Cabeza  y Dra. Tamara Barreto Cruz</p>    <p class=MsoNormal style='text-align:justify'><o:p></o:p></p>    <p class=MsoHeading9>RESUMEN</p>    <p class=MsoBodyText3><span style='font-size:11.0pt;mso-bidi-font-size:10.0pt; font-family:"CG Times";mso-bidi-font-weight:bold'>Se realizó un estudio transversal  descriptivo que incluyó los 457 diabéticos, de 30 consultorios médicos del municipio  Artemisa. Fueron encuestados y examinados 419 (91,6 %). La prevalencia resultó  en 2,25 %. El sexo femenino predominó (70,88 %) al igual que el tipo 2 de diabetes.  La edad media excedió los 60 años en uno y otro sexos. El hábito de fumar fue  más frecuente en el sexo masculino. El sedentarismo superó 50 % en los 2 sexos.  La prevalencia de hipertensión arterial fue de 68,66 % (70,27 % en mujeres y 64,75  % en hombres). Se detectaron cifras elevadas de tensión arterial en 65,19 % de  las mujeres hipertensas conocidas y en 69,69 % de los hombres, que seguían algún  tipo de tratamiento antihipertensivo. En 9,56 % de los pacientes se detectaron  cifras anormales de tensión arterial, sin diagnóstico ni tratamiento antihipertensivo  previos. Más de 60 % de los pacientes cumplían los criterios de sobrepeso y obesidad  (índice de masa corporal </span><span style='font-size:11.0pt; mso-bidi-font-size:10.0pt;font-family:Symbol;mso-ascii-font-family:"CG Times"; mso-hansi-font-family:"CG Times";mso-char-type:symbol;mso-symbol-font-family: Symbol;mso-bidi-font-weight:bold'><span style='mso-char-type:symbol;mso-symbol-font-family: Symbol'>&gt;</span></span><span style='font-size:11.0pt;mso-bidi-font-size: 10.0pt;font-family:"CG Times";mso-bidi-font-weight:bold'> 25 kg/ m<sup>2</sup>).  Se encontraron cifras de índice cintura/cadera de riesgo en 88,47 % de las mujeres  y en 81,15 % de los hombres. Evidentemente el sedentarismo, la obesidad y la hipertensión  arterial son fenómenos que afectan con frecuencia a los diabéticos. Se deben establecer  estrategias que promuevan cambios en el estilo de vida de este grupo de pacientes.  </span></p>    <p class=MsoNormal style='text-align:justify'><i><span style='font-size:11.0pt; mso-bidi-font-size:10.0pt;font-family:"CG Times";mso-bidi-font-weight:bold'>DeCS</span></i><span style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times"; mso-bidi-font-weight:bold'>: DIABETES MELLITUS/ complicaciones; DIABETES MELLITUS/  epidemiología; FACTORES DE RIESGO; HIPERTENSION; OBESIDAD; TABAQUISMO.</span></p>    <p class=MsoNormal style='text-align:justify'>&nbsp;</p>    ]]></body>
<body><![CDATA[<p class=MsoNormal style='text-align:justify'>&nbsp;</p>    <p class=MsoNormal style='text-align:justify'><span lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times"; mso-ansi-language:ES-MX;mso-bidi-font-weight:bold'>En las Américas viven alrededor  de 30 000 000 de diabéticos según datos de la Organización Panamericana de Salud  (OPS).<sup>1</sup> En los EE. UU. la diabetes mellitus (DM) ocupa el cuarto lugar  entre los motivos de consulta médica y constituye una causa importante de incapacidad  y mortalidad prematuras, con una prevalencia de 0,30 % el tipo 1 y 3-5 % el tipo  2 (aumentando a 10-15 % en los mayores de 50 años).<sup>2</sup></span></p>    <p class=MsoBodyTextIndent style='text-indent:0cm;line-height:normal'><span lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times"; mso-bidi-font-weight:bold'>En el diabético, el riesgo relativo (RR) de desarrollar  ceguera, insuficiencia renal crónica terminal (IRCT), infarto agudo de miocardio  (IMA), enfermedad cerebrovascular (ECV) y amputación es de 20, 25, 2-5, 2-3 y  40 veces mayor, respectivamente, que en el sujeto no diabético.<sup>3</sup></span></p>    <p class=MsoNormal style='text-align:justify'><span lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times"; mso-fareast-font-family:PMingLiU;mso-ansi-language:ES-MX;mso-bidi-font-weight: bold'>Las lesiones vasculares son la primera causa de muerte en los diabéticos,<sup>4</sup>  estando entre los hallazgos necrópsicos más frecuentes en la DM: la aterosclerosis  moderada o severa.<sup>5</sup> El estado diabético constituye un factor de riesgo  vascular de aterosclerosis fundamental, toda vez que la hiperglicemia crónica  conlleva al aumento de triglicéridos y disminución de las HDL-colesterol. Son  peculiaridades en la DM las alteraciones morfológicas y la glucosilación de las  lipoproteínas de baja densidad (LDL), lo que las hace más susceptibles a la captación  por los macrófagos de la pared vascular y la consecuente formación de la placa  de ateroma.<sup>6</sup> </span></p>    <p class=MsoNormal style='text-align:justify'><span lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times"; mso-fareast-font-family:PMingLiU;mso-ansi-language:ES-MX;mso-bidi-font-weight: bold'>La inespecificidad relativa de la glucosilación no enzimática de las proteínas  comprende no solo a la hemoglobina sino también a las proteínas séricas y de membrana,  las LDL (ya referido), las proteínas de los nervios periféricos (tubulina) y proteínas  estructurales; todo lo cual ha generado la idea de que la hiperglicemia induce  modificaciones muy extensas en las proteínas celulares y estructurales, lo que  contribuye a las complicaciones a largo plazo.<sup>2</sup></span></p>    <p class=MsoBodyTextIndent style='text-indent:0cm;line-height:normal'><span lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times"; mso-fareast-font-family:PMingLiU;mso-bidi-font-weight:bold'>Los principales factores  de riesgo cardiovascular como son la hipertensión arterial (HTA), la hipercolesterolemia  y el tabaquismo tienen efecto sinérgico con la DM para el surgimiento de aterosclerosis.  La HTA es aproximadamente 2 veces más común en población diabética que en población  general y su prevalencia aumenta con la edad.<sup>7</sup> Se ha documentado con  solidez el efecto devastador que ejerce la HTA sistémica sobre el desarrollo del  daño microvascular y macrovascular. Se estima que entre 35 y 75 % de las complicaciones  diabéticas son atribuibles a la HTA y comparativamente, las tasas de supervivencia  son superiores en diabéticos que exhiben valores de normotensión.<sup>8</sup></span></p>    <p class=MsoBodyTextIndent style='text-indent:0cm;line-height:normal'><span lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times"; mso-fareast-font-family:PMingLiU;mso-bidi-font-weight:bold'>En los diabéticos  hipertensos el riesgo de IMA aumenta 8 veces y llega a 20 veces si se agrega la  hipercolesterolemia.<sup>2</sup> La cardiopatía isquémica (CI) es una complicación  frecuente en el curso de la DM y causa de una elevada morbilidad y mortalidad  en estos pacientes, este riesgo aumenta con la edad y el tiempo de evolución de  la enfermedad.<sup>9</sup> </span></p>    <p class=MsoBodyTextIndent style='text-indent:0cm;line-height:normal'><span lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times"; mso-fareast-font-family:PMingLiU;mso-bidi-font-weight:bold'>Después de los 50  años de edad, las causas más frecuentes de muerte en diabéticos son el IMA y la  aterosclerosis.<sup>10 </sup>La enfermedad cardiovascular es una causa importante  de muerte en ambos tipos de diabetes y los niveles de hemoglobina glicosilada  se asocian significativamente con anormalidades de la coagulación, dislipidemias  y la mortalidad por IMA.<sup>11</sup></span></p>    <p class=MsoNormal style='text-align:justify'><span lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times"; mso-ansi-language:ES-MX;mso-bidi-font-weight:bold'>Algunos autores plantean que  la mortalidad por ECV, tanto temprana como tardía, aumenta cuando la DM está presente,  porque esta provoca un envejecimiento prematuro de los macrovasos y microvasos  en el lecho vasculocerebral. En un estudio de 265 pacientes que ingresaron con  el diagnóstico de AVE, <i>Lang</i> <i>J</i> y otros,<sup>12</sup> determinaron  que 15,85 % eran diabéticos y se encontraban descontrolados de su enfermedad.  </span></p>    <p class=MsoNormal style='text-align:justify'><span lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times"; mso-ansi-language:ES-MX;mso-bidi-font-weight:bold'>Ante esas evidencias los autores  se propusieron realizar este trabajo en el nivel primario de salud, con el objetivo  de conocer los principales factores clínicos de riesgo cardiovascular que afectan  a la población cubana diabética.</span></p>    ]]></body>
<body><![CDATA[<p class=MsoHeading7 style='text-align:justify'><span lang=ES-MX>MÉTODOS</span></p>    <p class=MsoNormal style='text-align:justify'><span style='font-size:11.0pt; mso-bidi-font-size:10.0pt;font-family:"CG Times";mso-bidi-font-weight:bold'>Se  realizó un estudio transversal descriptivo que incluyó 3 de las 4 áreas de salud  con que cuenta el municipio Artemisa</span><span lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times"; mso-ansi-language:ES-MX;mso-bidi-font-weight:bold'>. </span><span style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times"; mso-bidi-font-weight:bold'>Se escogieron, de forma aleatoria, 30 consultorios  médicos. En cada uno se encuestaron y examinaron todos los pacientes diabéticos  que lo permitieron, 419 pacientes para 91,6 % de los que aparecían dispensarizados  en la ficha familiar de los consultorios (457 en total); 38 pacientes no fueron  incluidos por los motivos que siguen:</span></p>    <p class=MsoNormal style='text-align:justify'><span lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times"; mso-ansi-language:ES-MX;mso-bidi-font-weight:bold'>Fuera del área<span style='mso-tab-count:4'>                                     </span>19</span></p>    <p class=MsoNormal style='text-align:justify'><span lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times"; mso-ansi-language:ES-MX;mso-bidi-font-weight:bold'>Fuera del país<span style='mso-tab-count:4'>                                     </span> 3</span></p>    <p class=MsoNormal style='text-align:justify'><span lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times"; mso-ansi-language:ES-MX;mso-bidi-font-weight:bold'>Encamados (no cooperaron)<span style='mso-tab-count:2'>                 </span>6</span></p>    <p class=MsoNormal style='text-align:justify'><span lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times"; mso-ansi-language:ES-MX;mso-bidi-font-weight:bold'>Negados a participar del estudio<span style='mso-tab-count:1'>           </span>1</span></p>    <p class=MsoNormal style='text-align:justify'><span lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times"; mso-ansi-language:ES-MX;mso-bidi-font-weight:bold'>Ingresados<span style='mso-tab-count:4'>                                           </span>8</span></p>    <p class=MsoNormal style='text-align:justify'><span lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times"; mso-ansi-language:ES-MX;mso-bidi-font-weight:bold'>Becados<span style='mso-tab-count:4'>                                              </span>1</span></p>    <p class=MsoNormal style='text-align:justify'><span lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times"; mso-ansi-language:ES-MX;mso-bidi-font-weight:bold'><span style='mso-tab-count: 1'>            </span></span></p>    <p class=MsoNormal style='text-align:justify'><span lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times"; mso-ansi-language:ES-MX;mso-bidi-font-weight:bold'>Posteriormente se confeccionó  una base de datos utilizando el programa computadorizado MICROSTA. Para establecer  asociación entre las variables cualitativas se empleó la prueba de chi-cuadrado  y para la comparación de las medias, la prueba t de Student. Se consignó un nivel  de significación de p</span><span lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol; mso-ascii-font-family:"CG Times";mso-hansi-font-family:"CG Times";mso-ansi-language: ES-MX;mso-char-type:symbol;mso-symbol-font-family:Symbol;mso-bidi-font-weight: bold'><span style='mso-char-type:symbol;mso-symbol-font-family:Symbol'>&lt;</span></span><span lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times"; mso-ansi-language:ES-MX;mso-bidi-font-weight:bold'> 0,05. </span></p><h6 style='text-align:justify;line-height:normal'><span lang=ES-MX>Definiciones  operacionales</span></h6>    ]]></body>
<body><![CDATA[<p class=MsoNormal style='margin-left:36.0pt;text-align:justify;text-indent: 11.4pt;mso-list:l0 level1 lfo2;tab-stops:list 62.0pt'><span style='font-family:Arial;mso-ascii-font-family: "Times New Roman";mso-fareast-font-family:"\@MingLiU";mso-bidi-font-family: "Times New Roman"'>–</span><span style='mso-fareast-font-family:"\@MingLiU"; mso-hansi-font-family:Arial'> </span><span lang=ES-MX style='font-size:11.0pt; mso-bidi-font-size:10.0pt;font-family:"CG Times";mso-ansi-language:ES-MX; mso-bidi-font-weight:bold'>Hipertensión arterial (HTA): se consideró cuando las  cifras de tensión arterial sistólica </span><span lang=ES-MX style='font-size: 11.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol;mso-ascii-font-family:"CG Times"; mso-hansi-font-family:"CG Times";mso-ansi-language:ES-MX;mso-char-type:symbol; mso-symbol-font-family:Symbol;mso-bidi-font-weight:bold'><span style='mso-char-type:symbol;mso-symbol-font-family:Symbol'>³</span></span><span lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times"; mso-ansi-language:ES-MX;mso-bidi-font-weight:bold'> 140 mm de Hg y/o las cifras  de tensión arterial diastólica </span><span lang=ES-MX style='font-size:11.0pt; mso-bidi-font-size:10.0pt;font-family:Symbol;mso-ascii-font-family:"CG Times"; mso-hansi-font-family:"CG Times";mso-ansi-language:ES-MX;mso-char-type:symbol; mso-symbol-font-family:Symbol;mso-bidi-font-weight:bold'><span style='mso-char-type:symbol;mso-symbol-font-family:Symbol'>³</span></span><span lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times"; mso-ansi-language:ES-MX;mso-bidi-font-weight:bold'> 90 mm de Hg. Se tomaron como  referencia los valores por el Programa Nacional de Prevención, Diagnóstico, Evaluación  y Control de la Hipertensión Arterial. </span></p>    <p class=MsoNormal style='margin-left:36.0pt;text-align:justify;text-indent: 11.4pt;mso-list:l0 level1 lfo2;tab-stops:list 62.0pt'><span style='font-family:Arial;mso-ascii-font-family: "Times New Roman";mso-fareast-font-family:"\@MingLiU";mso-bidi-font-family: "Times New Roman"'>–</span><span style='font-size:7.0pt;mso-fareast-font-family: "\@MingLiU"'>&nbsp;</span><span lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size: 10.0pt;font-family:"CG Times";mso-ansi-language:ES-MX;mso-bidi-font-weight: bold'>HTA tratada controlada: HTA bajo tratamiento y normal en el momento del  examen físico.</span></p>    <p class=MsoNormal style='margin-left:36.0pt;text-align:justify;text-indent: 11.4pt;mso-list:l0 level1 lfo2;tab-stops:list 62.0pt'><span style='font-family:Arial;mso-ascii-font-family: "Times New Roman";mso-fareast-font-family:"\@MingLiU";mso-bidi-font-family: "Times New Roman"'>–</span><span style='mso-fareast-font-family:"\@MingLiU"; mso-hansi-font-family:Arial'> </span><span lang=ES-MX style='font-size:11.0pt; mso-bidi-font-size:10.0pt;font-family:"CG Times";mso-ansi-language:ES-MX; mso-bidi-font-weight:bold'>HTA tratada no controlada: HTA bajo tratamiento, pero  anormal en el momento del examen físico.</span></p>    <p class=MsoNormal style='margin-left:36.0pt;text-align:justify;text-indent: 11.4pt;mso-list:l0 level1 lfo2;tab-stops:list 62.0pt'><span style='font-family:Arial;mso-ascii-font-family: "Times New Roman";mso-fareast-font-family:"\@MingLiU";mso-bidi-font-family: "Times New Roman"'>–</span><span style='mso-fareast-font-family:"\@MingLiU"; mso-hansi-font-family:Arial'> </span><span lang=ES-MX style='font-size:11.0pt; mso-bidi-font-size:10.0pt;font-family:"CG Times";mso-ansi-language:ES-MX; mso-bidi-font-weight:bold'>HTA detectada: sin tratamiento, no referida por el  paciente pero anormal en el momento del examen.</span></p>    <p class=MsoNormal style='margin-left:36.0pt;text-align:justify;text-indent: 11.4pt;mso-list:l0 level1 lfo2;tab-stops:list 62.0pt'><span style='font-family:Arial;mso-ascii-font-family: "Times New Roman";mso-fareast-font-family:"\@MingLiU";mso-bidi-font-family: "Times New Roman"'>–</span><span lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size: 10.0pt;font-family:"CG Times";mso-ansi-language:ES-MX;mso-bidi-font-weight: bold'> HTA referida: sin tratamiento, referida por el paciente y normal en el  momento del examen médico.</span></p>    <p class=MsoNormal style='margin-left:36.0pt;text-align:justify;text-indent: 11.4pt;mso-list:l0 level1 lfo2;tab-stops:list 62.0pt'><span style='font-family:Arial;mso-ascii-font-family: "Times New Roman";mso-fareast-font-family:"\@MingLiU";mso-bidi-font-family: "Times New Roman"'>–</span><span style='mso-fareast-font-family:"\@MingLiU"; mso-hansi-font-family:Arial'> </span><span lang=ES-MX style='font-size:11.0pt; mso-bidi-font-size:10.0pt;font-family:"CG Times";mso-ansi-language:ES-MX; mso-bidi-font-weight:bold'>Índice de Quetelet o Índice de masa corporal (IMC):  constituye el cociente del peso (kg)/talla (m)<sup>2</sup> y se clasificaron como  sigue: </span></p><h3 style='text-align:justify'><i><span lang=ES-MX style='font-size:11.0pt; mso-bidi-font-size:10.0pt;font-family:"CG Times";font-weight:normal'>Valor de  IMC</span></i><span lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt; font-family:"CG Times";font-weight:normal'><span style='mso-tab-count:1'>   </span><i>Clasificación</i></span></h3><h3 style='margin-right:36.0pt;margin-left:36.0pt;text-align:justify'><span lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times"; font-weight:normal'>&lt;20<span style='mso-tab-count:1'>    </span>Bajo peso</span></h3>    <p class=MsoNormal style='margin-right:36.0pt;margin-left:36.0pt'><span lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times"; mso-ansi-language:ES-MX;mso-bidi-font-weight:bold'>20-25<span style='mso-tab-count: 1'>   </span>Normopeso</span><span style='mso-bidi-font-size:12.0pt'><o:p></o:p></span></p>    <p class=MsoNormal style='text-align:justify'><span lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times"; mso-ansi-language:ES-MX;mso-bidi-font-weight:bold'>25,1-29,9<span style='mso-tab-count:1'>         </span>Sobrepeso</span></p>    <p class=MsoNormal style='text-align:justify'><span lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times"; mso-ansi-language:ES-MX;mso-bidi-font-weight:bold'>30 o más<span style='mso-tab-count:1'>          </span> Obeso</span></p>    <p class=MsoNormal style='text-align:justify'><span style='font-size:11.0pt; mso-bidi-font-size:10.0pt;font-family:"CG Times"'>Índice cintura/cadera (ICC):  es el cociente de la circunferencia de cintura medida al nivel del ombligo (cm)  y la circunferencia de cadera, medida al nivel de la máxima prominencia de los  glúteos (cm). Se consideró como valor de riesgo el resultado de este cociente  mayor que 0,8 en mujeres y 0,9 en hombres</span>.</p>    ]]></body>
<body><![CDATA[<p class=MsoNormal style='text-align:justify'><b><span style='font-family:Arial'>RESULTADOS</span></b></p>    <p class=MsoHeading8>Características  generales del grupo</p>    <p class=MsoBodyText><span style='font-size:11.0pt;mso-bidi-font-size:10.0pt; font-family:"CG Times";mso-ansi-language:ES;mso-bidi-font-weight:bold'>El área  estudiada incluyó una población de 20 338 habitantes; en la cual aparecían en  las fichas familiares de los consultorios médicos, 457 pacientes registrados con  el diagnóstico de DM, resultando en una prevalencia de 2,25 %.</span></p>    <p class=MsoBodyText><span style='font-size:11.0pt;mso-bidi-font-size:10.0pt; font-family:"CG Times";mso-ansi-language:ES;mso-bidi-font-weight:bold'>La edad  media en el sexo femenino resultó de 63,14 ± 14,29 años y 62,41 ± 14,42 años,  en el masculino (p=NS). El grupo etáreo que agrupó la mayor cantidad de pacientes  fue el mayor de 60 años en los 2 sexos con 66,33 % entre las mujeres y 62,29 %  entre los hombres (tabla 1). </span></p>    <p class=MsoBodyText align=center style='text-align:center'><i><span lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times"; mso-bidi-font-weight:bold'>Tabla 1</span></i><span lang=ES-MX style='font-size: 11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";mso-bidi-font-weight: bold'>. Distribución por grupos de edades según el sexo</span></p>    <div align=center>  <table border=0 cellspacing=0 cellpadding=0 style='border-collapse:collapse;  mso-table-layout-alt:fixed;mso-padding-alt:0cm 3.5pt 0cm 3.5pt'> <tr> <td width=120 rowspan=2 valign=top style='width:89.75pt;border:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>Grupos</span></p>    <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>etáreos</span></p>    <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>(años)</span></p></td><td width=239 colspan=2 valign=top style='width:179.55pt;border:solid #786A19 .75pt;   border-left:none;mso-border-left-alt:solid #786A19 .75pt;padding:0cm 3.5pt 0cm 3.5pt'>      <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>Sexo femenino</span></p>    ]]></body>
<body><![CDATA[<p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   text-transform:uppercase;mso-bidi-font-weight:bold'>(</span><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>n<span style='text-transform:uppercase'> = 297)</span></span></p></td><td width=239 colspan=2 valign=top style='width:179.6pt;border:solid #786A19 .75pt;   border-left:none;mso-border-left-alt:solid #786A19 .75pt;padding:0cm 3.5pt 0cm 3.5pt'>      <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>Sexo masculino</span></p>    <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   text-transform:uppercase;mso-bidi-font-weight:bold'>(</span><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>n<span style='text-transform:uppercase'> = 122)</span></span></p></td></tr>  <tr> <td width=120 valign=top style='width:89.75pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>n</span></p></td><td width=120 valign=top style='width:89.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>%</span></p></td><td width=120 valign=top style='width:89.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>n</span></p></td><td width=120 valign=top style='width:89.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>%</span></p></td></tr> <tr> <td width=120 valign=top style='width:89.75pt;border:solid #786A19 .75pt;   border-top:none;mso-border-top-alt:solid #786A19 .75pt;padding:0cm 3.5pt 0cm 3.5pt'>      <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>&lt; 15</span></p></td><td width=120 valign=top style='width:89.75pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>4</span></p></td><td width=120 valign=top style='width:89.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>1,35</span></p></td><td width=120 valign=top style='width:89.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     ]]></body>
<body><![CDATA[<p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>3</span></p></td><td width=120 valign=top style='width:89.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>2,46</span></p></td></tr> <tr> <td width=120 valign=top style='width:89.75pt;border:solid #786A19 .75pt;   border-top:none;mso-border-top-alt:solid #786A19 .75pt;padding:0cm 3.5pt 0cm 3.5pt'>      <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>15-29</span></p></td><td width=120 valign=top style='width:89.75pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>4</span></p></td><td width=120 valign=top style='width:89.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>1,35</span></p></td><td width=120 valign=top style='width:89.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>1</span></p></td><td width=120 valign=top style='width:89.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>0,82</span></p></td></tr> <tr> <td width=120 valign=top style='width:89.75pt;border:solid #786A19 .75pt;   border-top:none;mso-border-top-alt:solid #786A19 .75pt;padding:0cm 3.5pt 0cm 3.5pt'>      <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>30-44</span></p></td><td width=120 valign=top style='width:89.75pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>15</span></p></td><td width=120 valign=top style='width:89.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>5,05</span></p></td><td width=120 valign=top style='width:89.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     ]]></body>
<body><![CDATA[<p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>7</span></p></td><td width=120 valign=top style='width:89.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>5,74</span></p></td></tr> <tr> <td width=120 valign=top style='width:89.75pt;border:solid #786A19 .75pt;   border-top:none;mso-border-top-alt:solid #786A19 .75pt;padding:0cm 3.5pt 0cm 3.5pt'>      <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>45-59</span></p></td><td width=120 valign=top style='width:89.75pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>77</span></p></td><td width=120 valign=top style='width:89.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>25,92</span></p></td><td width=120 valign=top style='width:89.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>35</span></p></td><td width=120 valign=top style='width:89.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>28,69</span></p></td></tr> <tr> <td width=120 valign=top style='width:89.75pt;border:solid #786A19 .75pt;   border-top:none;mso-border-top-alt:solid #786A19 .75pt;padding:0cm 3.5pt 0cm 3.5pt'>      <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>60 o más</span></p></td><td width=120 valign=top style='width:89.75pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>197</span></p></td><td width=120 valign=top style='width:89.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>66,33</span></p></td><td width=120 valign=top style='width:89.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     ]]></body>
<body><![CDATA[<p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>76</span></p></td><td width=120 valign=top style='width:89.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>62,29</span></p></td></tr> <tr> <td width=599 colspan=5 valign=top style='width:448.9pt;border:solid #786A19 .75pt;   border-top:none;mso-border-top-alt:solid #786A19 .75pt;padding:0cm 3.5pt 0cm 3.5pt'>      <p class=MsoNormal align=center style='margin:0cm;margin-bottom:.0001pt;   text-align:center'><span   style='font-size:10.0pt;font-family:Arial'><o:p></o:p></span></p></td></tr>  <tr> <td width=120 rowspan=2 valign=top style='width:89.75pt;border:solid #786A19 .75pt;   border-top:none;mso-border-top-alt:solid #786A19 .75pt;padding:0cm 3.5pt 0cm 3.5pt'>      <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>Edad</span></p>    <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>Grupo</span></p></td><td width=120 valign=top style='width:89.75pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>Media</span></p></td><td width=120 valign=top style='width:89.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>DE</span></p></td><td width=120 valign=top style='width:89.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>Media</span></p></td><td width=120 valign=top style='width:89.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>DE</span></p></td></tr> <tr> <td width=120 valign=top style='width:89.75pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>63,1481</span></p></td><td width=120 valign=top style='width:89.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     ]]></body>
<body><![CDATA[<p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>14,2986</span></p></td><td width=120 valign=top style='width:89.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>62,4180</span></p></td><td width=120 valign=top style='width:89.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>14,4204</span></p></td></tr> <tr> <td width=599 colspan=5 valign=top style='width:448.9pt;border:solid #786A19 .75pt;   border-top:none;mso-border-top-alt:solid #786A19 .75pt;padding:0cm 3.5pt 0cm 3.5pt'>      <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>p = 0,3180</span></p></td></tr> </table></div>    <p class=MsoBodyText align=center style='text-align:center'><i><span lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times"; mso-bidi-font-weight:bold'>Fuente</span></i><span lang=ES-MX style='font-size: 11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";mso-bidi-font-weight: bold'>: Modelo de recolección del dato primario.</span></p>    <p class=MsoBodyText><span style='font-size:11.0pt;mso-bidi-font-size:10.0pt; font-family:"CG Times";mso-ansi-language:ES;mso-bidi-font-weight:bold'>Al dicotomizar  el tiempo de evolución referido por los pacientes, se encontró que: a la mayoría  de las mujeres se les había hecho el diagnóstico de DM entre 10 y 19 años antes  (40,68 %) y en los hombres el grupo entre 1 y 10 años fue el más frecuentemente  referido (40,98 %); sin embargo, al agruparlos se observó que entre 1 y 20 años  se incluyó la gran mayoría de los pacientes (70,51 % de las mujeres/ 78,68 % de  los hombres). De forma general, aunque el tiempo de evolución resultó algo mayor  en las mujeres (14,19 ± 9,79 años) contra 12,75 ± 9,43 años en los hombres, estas  diferencias no fueron significativas (p= 0,0837). </span></p>    <p class=MsoBodyText><span style='font-size:11.0pt;mso-bidi-font-size:10.0pt; font-family:"CG Times";mso-ansi-language:ES;mso-bidi-font-weight:bold'>La raza  blanca predominó en los 2 sexos con 78,79 % entre mujeres y 75,41 % entre hombres.  La mayor parte de las mujeres eran amas de casa (55,22 %) y 63,93 % de los hombres  y 31,99 % de las mujeres se encontraban jubilados de sus actividades laborales.  En cuanto al nivel de escolaridad la mayor cantidad de pacientes había vencido  los niveles primario y medio con 59,46 y 24,66 % para las mujeres y 43,44 y 33,61%  para los hombres, respectivamente. El tipo 2 de DM fue el más frecuente para los  2 sexos con 92,93 % para las hembras y 93,44 % para los varones. La forma de inicio  más común resultó ser la aparición de síntomas clínicos: 79,66 % en el sexo femenino  y 79,51 % en el masculino, seguido en ambos grupos por el chequeo sin síntomas;  ningún paciente refirió haber comenzado con un cuadro de cetoacidosis diabética.</span></p>    <p class=MsoBodyText><i><span style='font-size:11.0pt;mso-bidi-font-size:10.0pt; font-family:"CG Times";mso-ansi-language:ES;mso-bidi-font-weight:bold'>Tabaquismo  y sedentarismo</span></i></p>    <p class=MsoBodyText><span style='font-size:11.0pt;mso-bidi-font-size:10.0pt; font-family:"CG Times";mso-ansi-language:ES;mso-bidi-font-weight:bold'>El hábito  de fumar se constató en 36,89 % de los hombres, superando a las mujeres que ostentaban  solo 13,18 %. De las mujeres 69,26 % y de los hombres 58,20 %, refirieron no practicar  ejercicios; 19,26 % de las mujeres y 24,59 % de los hombres, a veces y solo 11,49  % de las mujeres y 17,21 % de los hombres, de forma regular (fig. 1).</span></p>    <p class=MsoBodyText><span lang=ES-MX>&nbsp;</span></p>    ]]></body>
<body><![CDATA[<p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX><a href="/img/revistas/ibi/v23n1/fig0104104.jpg"><b><img src="/img/revistas/ibi/v23n1/nfig0104104.jpg" width="293" height="613" border="0"></b></a></span></p>    
<p class=MsoBodyText align=center style='text-align:center'><i><span lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt'>Fig. 1</span></i><span lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt'>. Frecuencia de  práctica de ejercicios en el grupo (n= 418).</span></p>    <p class=MsoBodyText><i><span style='font-size:11.0pt;mso-bidi-font-size:10.0pt; font-family:"CG Times";mso-ansi-language:ES;mso-bidi-font-weight:bold'>Hipertensión  arterial</span></i></p>    <p class=MsoBodyText><span style='font-size:11.0pt;mso-bidi-font-size:10.0pt; font-family:"CG Times";mso-ansi-language:ES;mso-bidi-font-weight:bold'>La prevalencia  de hipertensión arterial (HTA) en el grupo estudiado fue de 68,66 % (70,27 % de  las mujeres/64,75 % de los hombres), este valor incluye los casos tratados, controlados  o no, y los casos detectados. Se detectaron cifras elevadas de TA (</span><span lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size: 10.0pt;font-family:Symbol;mso-ascii-font-family:"CG Times";mso-hansi-font-family: "CG Times";mso-char-type:symbol;mso-symbol-font-family:Symbol;mso-bidi-font-weight: bold'><span style='mso-char-type:symbol;mso-symbol-font-family:Symbol'>³</span></span><span lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times"; mso-bidi-font-weight:bold'> 140/90 mm Hg) en 9,12 % de las mujeres y en 10,66  % de los hombres; en el momento del examen, este grupo (HTA detectada) desconocía  la posibilidad de padecer la entidad y no seguía tratamiento antihipertensivo</span><span style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times"; mso-ansi-language:ES;mso-bidi-font-weight:bold'> (tabla 2). Se detectaron cifras  de tensión arterial (TA) anormalmente elevadas en 65,19 % de las mujeres y en  69,69 % de los hombres tratados con algún fármaco antihipertensivo (fig. 2).</span></p>    <p class=MsoBodyText align=center style='text-align:center'><i><span lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times"; mso-bidi-font-weight:bold'>Tabla 2</span></i><span lang=ES-MX style='font-size: 11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";mso-bidi-font-weight: bold'>. Hipertensión arterial (HTA) y estado de control según el sexo</span></p>    <div align=center>  <table border=0 cellspacing=0 cellpadding=0 style='border-collapse:collapse;  mso-table-layout-alt:fixed;mso-padding-alt:0cm 3.5pt 0cm 3.5pt'> <tr> <td width=125 rowspan=2 valign=top style='width:93.75pt;border:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   text-transform:uppercase;mso-bidi-font-weight:bold'>HTA</span></p></td><td width=237 colspan=2 valign=top style='width:177.55pt;border:solid #786A19 .75pt;   border-left:none;mso-border-left-alt:solid #786A19 .75pt;padding:0cm 3.5pt 0cm 3.5pt'>      <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>Sexo femenino</span></p>    <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>(n = 296)*</span></p></td><td width=237 colspan=2 valign=top style='width:177.6pt;border:solid #786A19 .75pt;   border-left:none;mso-border-left-alt:solid #786A19 .75pt;padding:0cm 3.5pt 0cm 3.5pt'>      <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>Sexo masculino</span></p>    ]]></body>
<body><![CDATA[<p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>(n = 122)</span></p></td></tr> <tr> <td width=118 valign=top style='width:88.75pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>n</span></p></td><td width=118 valign=top style='width:88.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>%</span></p></td><td width=118 valign=top style='width:88.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>n</span></p></td><td width=118 valign=top style='width:88.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>%</span></p></td></tr> <tr> <td width=125 valign=top style='width:93.75pt;border:solid #786A19 .75pt;   border-top:none;mso-border-top-alt:solid #786A19 .75pt;padding:0cm 3.5pt 0cm 3.5pt'>      <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>No</span></p>    <p class=MsoBodyText align=center style='text-align:center'><span   lang=ES-MX><o:p></o:p></span></p></td><td width=118 valign=top style='width:88.75pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>81</span></p></td><td width=118 valign=top style='width:88.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>27,36</span></p></td><td width=118 valign=top style='width:88.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>41</span></p></td><td width=118 valign=top style='width:88.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     ]]></body>
<body><![CDATA[<p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>33,61</span></p></td></tr> <tr> <td width=125 valign=top style='width:93.75pt;border:solid #786A19 .75pt;   border-top:none;mso-border-top-alt:solid #786A19 .75pt;padding:0cm 3.5pt 0cm 3.5pt'>      <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>Tratada</span></p>    <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>controlada</span></p></td><td width=118 valign=top style='width:88.75pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>63</span></p></td><td width=118 valign=top style='width:88.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>21,28</span></p></td><td width=118 valign=top style='width:88.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>20</span></p></td><td width=118 valign=top style='width:88.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>16,39</span></p></td></tr> <tr> <td width=125 valign=top style='width:93.75pt;border:solid #786A19 .75pt;   border-top:none;mso-border-top-alt:solid #786A19 .75pt;padding:0cm 3.5pt 0cm 3.5pt'>      <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>Tratada no</span></p>    <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>controlada</span></p></td><td width=118 valign=top style='width:88.75pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>118</span></p></td><td width=118 valign=top style='width:88.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     ]]></body>
<body><![CDATA[<p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>39,86</span></p></td><td width=118 valign=top style='width:88.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>46</span></p></td><td width=118 valign=top style='width:88.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>37,70</span></p></td></tr> <tr> <td width=125 valign=top style='width:93.75pt;border:solid #786A19 .75pt;   border-top:none;mso-border-top-alt:solid #786A19 .75pt;padding:0cm 3.5pt 0cm 3.5pt'>      <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>Detectada</span></p>    <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>(sin tratamiento)</span></p></td><td width=118 valign=top style='width:88.75pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>27</span></p></td><td width=118 valign=top style='width:88.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>9,12</span></p></td><td width=118 valign=top style='width:88.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>13</span></p></td><td width=118 valign=top style='width:88.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>10,66</span></p></td></tr> <tr> <td width=125 valign=top style='width:93.75pt;border:solid #786A19 .75pt;   border-top:none;mso-border-top-alt:solid #786A19 .75pt;padding:0cm 3.5pt 0cm 3.5pt'>      <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>Referida</span></p>    ]]></body>
<body><![CDATA[<p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>(sin tratamiento)</span></p></td><td width=118 valign=top style='width:88.75pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>7</span></p></td><td width=118 valign=top style='width:88.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>2,36</span></p></td><td width=118 valign=top style='width:88.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>2</span></p></td><td width=118 valign=top style='width:88.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>1,64</span></p></td></tr> <tr> <td width=599 colspan=5 valign=top style='width:448.9pt;border:solid #786A19 .75pt;   border-top:none;mso-border-top-alt:solid #786A19 .75pt;padding:0cm 3.5pt 0cm 3.5pt'>      <p class=MsoNormal align=center style='margin:0cm;margin-bottom:.0001pt;   text-align:center'><span   style='font-size:10.0pt;font-family:Arial'><o:p></o:p></span></p></td></tr>  <tr> <td width=125 rowspan=2 valign=top style='width:93.75pt;border:solid #786A19 .75pt;   border-top:none;mso-border-top-alt:solid #786A19 .75pt;padding:0cm 3.5pt 0cm 3.5pt'>      <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>TA</span></p>    <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>sistólica</span></p>    <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>(mm Hg)</span></p></td><td width=118 valign=top style='width:88.75pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>Media</span></p></td><td width=118 valign=top style='width:88.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     ]]></body>
<body><![CDATA[<p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>DE</span></p></td><td width=118 valign=top style='width:88.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>Media</span></p></td><td width=118 valign=top style='width:88.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>DE</span></p></td></tr> <tr> <td width=118 valign=top style='width:88.75pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-ansi-language:ES;mso-bidi-font-weight:bold'>135,91</span></p></td><td width=118 valign=top style='width:88.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-ansi-language:ES;mso-bidi-font-weight:bold'>23,01</span></p></td><td width=118 valign=top style='width:88.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-ansi-language:ES;mso-bidi-font-weight:bold'>137,33</span></p></td><td width=118 valign=top style='width:88.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-ansi-language:ES;mso-bidi-font-weight:bold'>23,37</span></p></td></tr> <tr>  <td width=599 colspan=5 valign=top style='width:448.9pt;border:solid #786A19 .75pt;   border-top:none;mso-border-top-alt:solid #786A19 .75pt;padding:0cm 3.5pt 0cm 3.5pt'>      <p class=MsoBodyText align=center style='text-align:center'><span   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-ansi-language:ES;mso-bidi-font-weight:bold'>p = 0,2837</span></p></td></tr>  <tr> <td width=125 rowspan=2 valign=top style='width:93.75pt;border:solid #786A19 .75pt;   border-top:none;mso-border-top-alt:solid #786A19 .75pt;padding:0cm 3.5pt 0cm 3.5pt'>      <p class=MsoBodyText align=center style='text-align:center'><span   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-ansi-language:ES;mso-bidi-font-weight:bold'>TA</span></p>    <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>diastólica</span></p>    ]]></body>
<body><![CDATA[<p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>(mm Hg)</span></p></td><td width=118 valign=top style='width:88.75pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>Media</span></p></td><td width=118 valign=top style='width:88.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>DE</span></p></td><td width=118 valign=top style='width:88.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>Media</span></p></td><td width=118 valign=top style='width:88.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>DE</span></p></td></tr> <tr> <td width=118 valign=top style='width:88.75pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>81,08</span></p></td><td width=118 valign=top style='width:88.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>11,09</span></p></td><td width=118 valign=top style='width:88.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>83,40</span></p></td><td width=118 valign=top style='width:88.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>12,15</span></p></td></tr> <tr> <td width=599 colspan=5 valign=top style='width:448.9pt;border:solid #786A19 .75pt;   border-top:none;mso-border-top-alt:solid #786A19 .75pt;padding:0cm 3.5pt 0cm 3.5pt'>      <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>p = 0,0297</span></p></td></tr> </table></div>    ]]></body>
<body><![CDATA[<p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times"; mso-bidi-font-weight:bold'>* se excluye 1 caso en que no se tomó el dato.    <br>  <i>Fuente</i>: Modelo de recolección del dato primario.</span></p>    <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX>&nbsp;</span></p>    <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX><a href="/img/revistas/ibi/v23n1/fig0204104.jpg"><b><img src="/img/revistas/ibi/v23n1/fig0204104.jpg" width="289" height="627" border="0"></b></a></span></p>    
<p class=MsoBodyText align=center style='text-align:center'><i><span lang=ES-MX>Fig. 2</span></i><span lang=ES-MX>. Estado de control de la tension  arterial en los pacientes tratados con fármacos antihipertensivos. <i>Fuente</i>:  tabla 2.</span></p>    <p class=MsoBodyText><i><span style='font-size:11.0pt;mso-bidi-font-size:10.0pt; font-family:"CG Times";mso-ansi-language:ES;mso-bidi-font-weight:bold'>Índice  de masa corporal-Índice cintura/cadera</span></i></p>    <p class=MsoBodyText><span style='font-size:11.0pt;mso-bidi-font-size:10.0pt; font-family:"CG Times";mso-ansi-language:ES;mso-bidi-font-weight:bold'>En 64,29  % de las mujeres y en 63,93 % de los hombres se obtuvieron valores de IMC mayores  que 25 kg/m<sup>2</sup>; solo 32,31 % de las mujeres y 31,97 % de los hombres  se encontraban dentro de los valores considerados como normales. La incidencia  de bajo peso fue baja en los 2 sexos (3,40 % de las mujeres y 4,10 % de los hombres).  No se encontraron diferencias significativas al comparar las medias de IMC entre  uno y otro sexos (p= 0,3983) (tabla 3). </span></p>    <p class=MsoBodyText align=center style='text-align:center'><i><span lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times"; mso-bidi-font-weight:bold'>Tabla 3</span></i><span lang=ES-MX style='font-size: 11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";mso-bidi-font-weight: bold'>. Índice de masa corporal (IMC), según el sexo</span></p>    <div align=center>  <table border=0 cellspacing=0 cellpadding=0 style='border-collapse:collapse;  mso-table-layout-alt:fixed;mso-padding-alt:0cm 3.5pt 0cm 3.5pt'> <tr> <td width=120 rowspan=2 valign=top style='width:90.25pt;border:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   text-transform:uppercase;mso-ansi-language:ES;mso-bidi-font-weight:bold'>IMC</span></p></td><td width=237 colspan=2 valign=top style='width:177.55pt;border:solid #786A19 .75pt;   border-left:none;mso-border-left-alt:solid #786A19 .75pt;padding:0cm 3.5pt 0cm 3.5pt'>      ]]></body>
<body><![CDATA[<p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>Sexo femenino</span></p>    <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>(n = 294)*</span></p></td><td width=237 colspan=2 valign=top style='width:177.6pt;border:solid #786A19 .75pt;   border-left:none;mso-border-left-alt:solid #786A19 .75pt;padding:0cm 3.5pt 0cm 3.5pt'>      <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>Sexo masculino</span></p>    <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>(n = 122)</span></p></td></tr> <tr> <td width=118 valign=top style='width:88.75pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>n</span></p></td><td width=118 valign=top style='width:88.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>%</span></p></td><td width=118 valign=top style='width:88.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>n</span></p></td><td width=118 valign=top style='width:88.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>%</span></p></td></tr> <tr> <td width=120 valign=top style='width:90.25pt;border:solid #786A19 .75pt;   border-top:none;mso-border-top-alt:solid #786A19 .75pt;padding:0cm 3.5pt 0cm 3.5pt'>      <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>&lt;20</span></p></td><td width=118 valign=top style='width:88.75pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>10</span></p></td><td width=118 valign=top style='width:88.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     ]]></body>
<body><![CDATA[<p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>3,40</span></p></td><td width=118 valign=top style='width:88.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>5</span></p></td><td width=118 valign=top style='width:88.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>4,10</span></p></td></tr> <tr> <td width=120 valign=top style='width:90.25pt;border:solid #786A19 .75pt;   border-top:none;mso-border-top-alt:solid #786A19 .75pt;padding:0cm 3.5pt 0cm 3.5pt'>      <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>20-25</span></p></td><td width=118 valign=top style='width:88.75pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>95</span></p></td><td width=118 valign=top style='width:88.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>32,31</span></p></td><td width=118 valign=top style='width:88.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>39</span></p></td><td width=118 valign=top style='width:88.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>31,97</span></p></td></tr> <tr> <td width=120 valign=top style='width:90.25pt;border:solid #786A19 .75pt;   border-top:none;mso-border-top-alt:solid #786A19 .75pt;padding:0cm 3.5pt 0cm 3.5pt'>      <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>25,1-29,9</span></p></td><td width=118 valign=top style='width:88.75pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>120</span></p></td><td width=118 valign=top style='width:88.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     ]]></body>
<body><![CDATA[<p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>40,82</span></p></td><td width=118 valign=top style='width:88.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>43</span></p></td><td width=118 valign=top style='width:88.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>35,24</span></p></td></tr> <tr> <td width=120 valign=top style='width:90.25pt;border:solid #786A19 .75pt;   border-top:none;mso-border-top-alt:solid #786A19 .75pt;padding:0cm 3.5pt 0cm 3.5pt'>      <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>30 o más</span></p></td><td width=118 valign=top style='width:88.75pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=EN-US   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-ansi-language:EN-US;mso-bidi-font-weight:bold'>69</span><span lang=EN-US   style='mso-ansi-language:EN-US'><o:p></o:p></span></p></td><td width=118 valign=top style='width:88.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=EN-US   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-ansi-language:EN-US;mso-bidi-font-weight:bold'>23,47</span><span   lang=EN-US style='mso-ansi-language:EN-US'><o:p></o:p></span></p></td><td width=118 valign=top style='width:88.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=EN-US   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-ansi-language:EN-US;mso-bidi-font-weight:bold'>35</span><span lang=EN-US   style='mso-ansi-language:EN-US'><o:p></o:p></span></p></td><td width=118 valign=top style='width:88.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=EN-US   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-ansi-language:EN-US;mso-bidi-font-weight:bold'>28,69</span><span   lang=EN-US style='mso-ansi-language:EN-US'><o:p></o:p></span></p></td></tr>  <tr> <td width=594 colspan=5 valign=top style='width:445.4pt;border:solid #786A19 .75pt;   border-top:none;mso-border-top-alt:solid #786A19 .75pt;padding:0cm 3.5pt 0cm 3.5pt'>      <p class=MsoNormal align=center style='margin:0cm;margin-bottom:.0001pt;   text-align:center'><![if !supportEmptyParas]>&nbsp;<![endif]><span   lang=EN-US style='font-size:10.0pt;font-family:Arial;mso-ansi-language:EN-US'><o:p></o:p></span></p></td></tr>  <tr> <td width=120 rowspan=2 valign=top style='width:90.25pt;border:solid #786A19 .75pt;   border-top:none;mso-border-top-alt:solid #786A19 .75pt;padding:0cm 3.5pt 0cm 3.5pt'>      <p class=MsoBodyText align=center style='text-align:center'><span lang=EN-US   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   text-transform:uppercase;mso-ansi-language:EN-US;mso-bidi-font-weight:bold'>IMC</span><span   lang=EN-US style='mso-ansi-language:EN-US'><o:p></o:p></span></p>    ]]></body>
<body><![CDATA[<p class=MsoBodyText align=center style='text-align:center'><span lang=EN-US   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   text-transform:uppercase;mso-ansi-language:EN-US;mso-bidi-font-weight:bold'>(</span><span   lang=EN-US style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:   "CG Times";mso-ansi-language:EN-US;mso-bidi-font-weight:bold'>kg<span   style='text-transform:uppercase'>/</span>m<sup><span style='text-transform:   uppercase'>2</span></sup><u><span style='text-transform:uppercase'>)</span></u></span><span   lang=EN-US style='mso-ansi-language:EN-US'><o:p></o:p></span></p></td><td width=118 valign=top style='width:88.75pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>Media</span></p></td><td width=118 valign=top style='width:88.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>DE</span></p></td><td width=118 valign=top style='width:88.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>Media</span></p></td><td width=118 valign=top style='width:88.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>DE</span></p></td></tr> <tr> <td width=118 valign=top style='width:88.75pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>27,04</span></p></td><td width=118 valign=top style='width:88.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>4,53</span></p></td><td width=118 valign=top style='width:88.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>26,92</span></p></td><td width=118 valign=top style='width:88.8pt;border-top:none;border-left:   none;border-bottom:solid #786A19 .75pt;border-right:solid #786A19 .75pt;   mso-border-top-alt:solid #786A19 .75pt;mso-border-left-alt:solid #786A19 .75pt;   padding:0cm 3.5pt 0cm 3.5pt'>     <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>4,30</span></p></td></tr> <tr> <td width=594 colspan=5 valign=top style='width:445.4pt;border:solid #786A19 .75pt;   border-top:none;mso-border-top-alt:solid #786A19 .75pt;padding:0cm 3.5pt 0cm 3.5pt'>      <p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX   style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";   mso-bidi-font-weight:bold'>p = 0,3983</span></p></td></tr> </table></div>    ]]></body>
<body><![CDATA[<p class=MsoBodyText align=center style='text-align:center'><span lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times"; mso-bidi-font-weight:bold'>* se excluyen 3 casos en que no se tomó el dato.</span></p>    <p class=MsoBodyText align=center style='text-align:center'><i><span lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times"; mso-bidi-font-weight:bold'>Fuente</span></i><span lang=ES-MX style='font-size: 11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";mso-bidi-font-weight: bold'>: Modelo de recolección del dato primario.</span></p>    <p class=MsoBodyText><span style='font-size:11.0pt;mso-bidi-font-size:10.0pt; font-family:"CG Times";mso-ansi-language:ES;mso-bidi-font-weight:bold'>Se encontraron  cifras de ICC en 88,47 % de las mujeres y en 81,15 % de los hombres y al comparar  las medias entre los 2 sexos se observó que, en el sexo masculino, este indicador  superaba, de forma significativa, al sexo opuesto (0,98 </span><span style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol; mso-ascii-font-family:"CG Times";mso-hansi-font-family:"CG Times";mso-ansi-language: ES;mso-char-type:symbol;mso-symbol-font-family:Symbol;mso-bidi-font-weight: bold'><span style='mso-char-type:symbol;mso-symbol-font-family:Symbol'>±</span></span><span style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times"; mso-ansi-language:ES;mso-bidi-font-weight:bold'> 0,09 <i>vs.</i> 0,91 </span><span style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol; mso-ascii-font-family:"CG Times";mso-hansi-font-family:"CG Times";mso-ansi-language: ES;mso-char-type:symbol;mso-symbol-font-family:Symbol;mso-bidi-font-weight: bold'><span style='mso-char-type:symbol;mso-symbol-font-family:Symbol'>±</span></span><span style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times"; mso-ansi-language:ES;mso-bidi-font-weight:bold'> 0,09) (p&lt; 0,01).</span></p>    <p class=MsoBodyText><b style='mso-bidi-font-weight:normal'><span style='font-family:Arial;mso-ansi-language:ES'>DISCUSIÓN</span></b></p>    <p class=MsoBodyText><span style='font-size:11.0pt;mso-bidi-font-size:10.0pt; font-family:"CG Times";mso-ansi-language:ES;mso-bidi-font-weight:bold'>La aterosclerosis  es la complicación más frecuente de la DM, contribuye a 75 % de todas las muertes  y es de 2-3 veces más frecuente en el paciente diabético que en el no diabético.  Las enfermedades coronarias y cerebrovasculares son también entre 2 y 3 veces  más comunes en diabéticos, así como la mortalidad posinfarto; de forma similar  el manejo clínico de la enfermedad coronaria es mucho más difícil por la frecuencia  con que se presenta la isquemia cardíaca de forma asintomática en estos pacientes.  </span></p>    <p class=MsoBodyText><span style='font-size:11.0pt;mso-bidi-font-size:10.0pt; font-family:"CG Times";mso-ansi-language:ES;mso-bidi-font-weight:bold'>Estos resultados  en cuanto a la edad, tiempo de evolución, color de la piel, predominio del tipo  2 de diabetes, el nivel de escolaridad bajo y el inicio por síntomas clínicos,  coinciden con los estudios realizados por otros investigadores.<sup>13-19</sup></span></p>    <p class=MsoBodyText><span style='font-size:11.0pt;mso-bidi-font-size:10.0pt; font-family:"CG Times";mso-ansi-language:ES;mso-bidi-font-weight:bold'>La HTA,  el tabaquismo, el sedentarismo y la hipercolesterolemia también incrementan el  riesgo de enfermedad coronaria en pacientes con diabetes. Existen suficientes  evidencias de que el hábito de fumar incrementa grandemente el riesgo de aterosclerosis,  particularmente en los diabéticos.<sup>20</sup> Como se puede ver la incidencia  de tabaquismo, aunque baja y predominantemente en el sexo masculino, lo que es  característico en la población cubana, parece aún alta tratándose de pacientes  diabéticos; por lo que debe constituir un reto disminuirla para los proveedores  de salud en el nivel primario.</span></p>    <p class=MsoBodyText><span style='font-size:11.0pt;mso-bidi-font-size:10.0pt; font-family:"CG Times";mso-ansi-language:ES;mso-bidi-font-weight:bold'>El ejercicio  físico es un arma fundamental en el tratamiento de estos pacientes, porque facilita  la reducción del peso corporal y aumenta la sensibilidad periférica a la insulina.  <i>Crespo JL</i> y otros,<sup>21 </sup>demostraron disminuciones significativas  de colesterol, triglicéridos y LDL-C después de 6 y 12 meses de un programa de  actividad física en un grupo de diabéticos. Resultó preocupante que más de 80  % de los diabéticos encuestados en este estudio, en los 2 sexos, refirieron no  practicar ejercicios de forma regular. <i>García R</i> y otros,<sup>19</sup> encuestaron  a un grupo de diabéticos de la tercera edad y encontraron que casi en 70 % se  cometió algún tipo de error al interrogársele sobre la práctica de ejercicio físico.  Por la similitud con el grupo de este estudio, los autores consideran importante  e inminente la necesidad de insistir en estos pacientes acerca de las bondades  del ejercicio físico regular en el control de la enfermedad y sus secuelas, así  como implicar a la familia en esta práctica tan saludable, pues se ha comprobado  el papel determinante del apoyo familiar en la realización de ejercicio físico,  sobre todo en pacientes de edad avanzada.<sup>22</sup></span></p>    <p class=MsoBodyText><span style='font-size:11.0pt;mso-bidi-font-size:10.0pt; font-family:"CG Times";mso-ansi-language:ES;mso-bidi-font-weight:bold'>Esta prevalencia  alta de HTA se corresponde con estudios previos de diseño similar.<sup>20,23,24</sup>  Sin embargo no es esta cifra lo más preocupante, sino el alto porcentaje de pacientes  que se encontraban descontrolados en el momento del examen, a pesar de estar bajo  tratamiento antihipertensivo, lo que debe poner en alerta a los médicos en el  nivel primario para la detección y el tratamiento precoces de la HTA especialmente  en el diabético. Esta también constituyó una preocupación de la Primera Encuesta  Nacional de Factores de Riesgo y Actividades Preventivas de Cuba referida por  la Comisión Nacional de Hipertensión Arterial.<sup>25</sup> </span></p>    <p class=MsoBodyText><span style='font-size:11.0pt;mso-bidi-font-size:10.0pt; font-family:"CG Times";mso-ansi-language:ES;mso-bidi-font-weight:bold'>La obesidad,  particularmente la abdominal, es otro factor muy vinculado con la tendencia al  desarrollo de aterosclerosis y diabetes. Su impacto pudiera estar mediado, al  menos en parte, a través de un incremento de la insulinorresistencia e hiperinsulinemia,  dislipidemias e HTA, o una combinación de todos estos factores. La prevalencia  de sobrepeso y obesidad superó 60 % de los pacientes de los 2 sexos, lo que habla  a favor de la importancia de estimular cambios en estilo de vida en los diabéticos  con el objetivo de lograr el peso ideal. Idénticos resultados en cuanto a prevalencia  de sobrepeso y obesidad se refieren en otros estudios.<sup>14,19-21,23</sup> </span></p>    ]]></body>
<body><![CDATA[<p class=MsoBodyText><span lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size: 10.0pt'>El ICC se ha convertido en otro parámetro de utilidad para medir el riesgo  de CI en seres humanos.<sup>26-29</sup> Aunque no abundan los trabajos que hayan  medido esta variable, se decidió hacerlo en el presente trabajo y se constataron  cifras de riesgo en más de 80 % de uno y otro sexos. Al analizar estos resultados  se consideró que este parámetro se debe convertir en una práctica rutinaria al  examinar al diabético, por el peligro que representa la obesidad abdominal para  ellos.<o:p></o:p></span></p>    <p class=MsoBodyText><b><span lang=EN-US style='font-family:Arial;mso-ansi-language: EN-US'>SUMMARY <o:p></o:p></span></b></p>    <p class=MsoBodyText><span lang=EN-US style='mso-ansi-language:EN-US'>A  cross-sectional descriptive study was conducted among 457 diabetic patients from  30 family physicians' offices of Artemisa municipality. 419 (91.6 %) were surveyed  and examined. There was a prevalence of 2.25 %. Females (70.88 %) and type 2 diabetes  predominated. The average age was over 60 in both sexes. Smoking was more frequent  in males. Sedentarism exceeded 50 % in both sexes. The prevalence of arterial  hypertension was 68.66 % (70.27 % in females and 64.75 % in males). High readings  of arterial hypertension were detected in 65.19 % of known hypertensive females  and in 69.9 % of men that were under some type of antihypertensive treatment.  Abnormal readings of arterial pressure were observed in 9.56 % of the patients  with no previous diagnosis, or antihypertenvie treatment. More than 60 % of the  patients fulfilled the overweight and obesity criteria (body mass index &gt;25  kg/m2). Figures of waist/hip risk index were found in 88.47 % of females and in  81.15 % of males. Obviously, sedentarism, obesity and arterial hypertension are  phenomena frequently affecting the diabetic patients. Strategies should be established  to promote changes in the lifestyle of this group of patients.<o:p></o:p></span></p>    <p class=MsoBodyText><i><span lang=EN-US style='mso-ansi-language:EN-US'>Subject  headings</span></i><span lang=EN-US style='mso-ansi-language:EN-US'>: DIABETES  MELLITUS/ complications; DIABETES MELLITUS/ epidemiology; RISK FACTORS; HYPERTENSION,  OBESITY; SMOKING.<o:p></o:p></span></p>    <!-- ref --><p class=MsoFooter style='text-align:justify'><b style='mso-bidi-font-weight: normal'><span style='font-family:Arial'>REFERENCIAS BIBLIOGRÁFICAS</span></b><!-- ref -->Ochi JW. A  population based study of diabetic mortality. </span><span lang=ES-MX      style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";      mso-ansi-language:ES-MX;mso-bidi-font-weight:bold'>Diabetes Care 1985;8:224-9.</span><span style='mso-bidi-font-size:12.0pt'><o:p></o:p></span></li><li class=MsoNormal style='mso-list:l1 level1 lfo5;tab-stops:list 36.0pt'><span      lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:      "CG Times";mso-ansi-language:ES-MX;mso-bidi-font-weight:bold'>Tellería MR,  Jiménez J, Rodríguez T, Mayans M, Sánchez R. Diabetes mellitus. Causas de muerte  y hallazgos necrópsicos en el anciano. </span><span      style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";      mso-bidi-font-weight:bold'>Rev Cubana Endocrinol 1994;5(1):52-6.</span><span      style='mso-bidi-font-size:12.0pt'><o:p></o:p></span></li><li class=MsoNormal style='mso-list:l1 level1 lfo5;tab-stops:list 36.0pt'><span      style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";      mso-bidi-font-weight:bold'>Collado Mesa F, Vidal MG, Durruty V, Sordo ME,  Montero RM. Diabetes mellitus como causa básica de muerte. </span><span      lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:      "CG Times";mso-ansi-language:ES-MX;mso-bidi-font-weight:bold'>Rev Cubana  Endocrinol 1998;9(3):184-93.</span><span style='mso-bidi-font-size:12.0pt'><o:p></o:p></span></li><li class=MsoNormal style='mso-list:l1 level1 lfo5;tab-stops:list 36.0pt'><span      lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:      "CG Times";mso-ansi-language:ES-MX;mso-bidi-font-weight:bold'>    Flores J, Bell      L. Diabetes mellitus e hipertensión arterial. Acta Médica 1997;7(1):122-32.</span><span style='mso-bidi-font-size:12.0pt'><o:p></o:p></span></li><li class=MsoNormal style='mso-list:l1 level1 lfo5;tab-stops:list 36.0pt'><span     lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:     "CG Times";mso-ansi-language:ES-MX;mso-bidi-font-weight:bold'>Sowers JR,      ]]></body>
<body><![CDATA[Zemel MB. </span><span lang=EN-US style='font-size:11.0pt;mso-bidi-font-size:     10.0pt;font-family:"CG Times";mso-ansi-language:EN-US;mso-bidi-font-weight:     bold'>Clinical implications of hypertension in the diabetic patient: a review.      Am J Hypertens 1990;3:415-24.</span><span lang=EN-US     style='mso-bidi-font-size:12.0pt;mso-ansi-language:EN-US'><o:p></o:p></span></li><li class=MsoNormal style='mso-list:l1 level1 lfo5;tab-stops:list 36.0pt'><span     lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:     "CG Times";mso-ansi-language:ES-MX;mso-bidi-font-weight:bold'>Roman W, Guanche      H, Molina A, Morcolella RM. Factores asociados a la presencia de cardiopatía isquémica      en diabéticos.</span><span lang=EN-US     style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol;     ]]></body>
<body><![CDATA[mso-ascii-font-family:"CG Times";mso-hansi-font-family:"CG Times";     mso-ansi-language:EN-US;mso-char-type:symbol;mso-symbol-font-family:Symbol;     mso-bidi-font-weight:bold'><span style='mso-char-type:symbol;mso-symbol-font-family:     Symbol'>[</span></span><span lang=ES-MX style='font-size:11.0pt;     mso-bidi-font-size:10.0pt;font-family:"CG Times";mso-ansi-language:ES-MX;     mso-bidi-font-weight:bold'>abstract</span><span lang=EN-US     style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol;     mso-ascii-font-family:"CG Times";mso-hansi-font-family:"CG Times";     mso-ansi-language:EN-US;mso-char-type:symbol;mso-symbol-font-family:Symbol;     mso-bidi-font-weight:bold'><span style='mso-char-type:symbol;mso-symbol-font-family:     ]]></body>
<body><![CDATA[Symbol'>]</span></span><span lang=ES-MX style='font-size:11.0pt;     mso-bidi-font-size:10.0pt;font-family:"CG Times";mso-ansi-language:ES-MX;     mso-bidi-font-weight:bold'>. Rev Cubana Endocrinol 1997;8(1):88.</span><span     style='mso-bidi-font-size:12.0pt'><o:p></o:p></span></li><li class=MsoNormal style='mso-list:l1 level1 lfo5;tab-stops:list 36.0pt'><span     lang=EN-US style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:     "CG Times";mso-ansi-language:EN-US;mso-bidi-font-weight:bold'>Keen H. Microalbuminuria:      marker of risk of diabetes complications. </span><span     lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:     "CG Times";mso-ansi-language:ES-MX;mso-bidi-font-weight:bold'>Care Elder      1993;5(11):338-402.</span><span style='mso-bidi-font-size:12.0pt'><o:p></o:p></span></li><li class=MsoNormal style='mso-list:l1 level1 lfo5;tab-stops:list 36.0pt'><span     ]]></body>
<body><![CDATA[lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:     "CG Times";mso-ansi-language:ES-MX;mso-bidi-font-weight:bold'>Batista ME,      Licea ME. Enfermedad muscular cardíaca diabética. Rev Cubana Endocrinol 1998;9(2):132-48.</span><span style='mso-bidi-font-size:12.0pt'><o:p></o:p></span></li><li class=MsoNormal style='mso-list:l1 level1 lfo5;tab-stops:list 36.0pt'><span     lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:     "CG Times";mso-ansi-language:ES-MX;mso-bidi-font-weight:bold'>Lang J, Licea      M, Borges R, Revilla R, Reina A. La diabetes mellitus y su relación con la enfermedad      cerebrovascular: estudio de 265 pacientes. Rev Cubana Endocrinol 1992;3(2):122-32.</span><span style='mso-bidi-font-size:12.0pt'><o:p></o:p></span></li><li class=MsoNormal style='mso-list:l1 level1 lfo5;tab-stops:list 36.0pt'><span     lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:     "CG Times";mso-ansi-language:ES-MX;mso-bidi-font-weight:bold'>Faget O, Hernández      Yero A, Licea M, Perich P, Seuc A. Caracterización clínica de los diabéticos con      ]]></body>
<body><![CDATA[ingreso ambulatorio. Rev Cubana Endocrinol 1994;5(2):81-9.</span><span style='mso-bidi-font-size:12.0pt'><o:p></o:p></span></li><li class=MsoNormal style='mso-list:l1 level1 lfo5;tab-stops:list 36.0pt'><span     lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:     "CG Times";mso-ansi-language:ES-MX;mso-bidi-font-weight:bold'>Jiménez J,      Rodríguez L, Tellería MR, Sigler A, Mayans M. Algunos aspectos clínicoepidemiológicos      de la diabetes mellitus en el municipio Morón. [abstract]. Rev Cubana Endocrinol      1997;8(1):73.</span><span     style='mso-bidi-font-size:12.0pt'><o:p></o:p></span></li><li class=MsoNormal style='mso-list:l1 level1 lfo5;tab-stops:list 36.0pt'><span     lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:     "CG Times";mso-ansi-language:ES-MX;mso-bidi-font-weight:bold'>Lozano E. Caracterización      clínica de la diabetes mellitus en 150 pacientes de 15 años y más de edad.[abstract].      ]]></body>
<body><![CDATA[Rev Cubana Endocrinol 1997;8(1):74.</span><span     style='mso-bidi-font-size:12.0pt'><o:p></o:p></span></li><li class=MsoNormal style='mso-list:l1 level1 lfo5;tab-stops:list 36.0pt'><span     lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:     "CG Times";mso-ansi-language:ES-MX;mso-bidi-font-weight:bold'>Rivero H, Uz      ME de la, Matos T, Trujillo L. Comportamiento de la diabetes mellitus en un grupo      de consultorios de área del policlínico “Hermanos Cruz” del municipio Pinar del      Río.[abstract]. Rev Cubana Endocrinol 1997;8(1):74.</span><span     style='mso-bidi-font-size:12.0pt'><o:p></o:p></span></li><li class=MsoNormal style='mso-list:l1 level1 lfo5;tab-stops:list 36.0pt'><span     lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:     "CG Times";mso-ansi-language:ES-MX;mso-bidi-font-weight:bold'>Rivero H, Uz      ]]></body>
<body><![CDATA[ME de la, Matos T, Trujillo L. Comportamiento de la diabetes mellitus en el período      de 1991 a 1994 en el centro de atención al diabético de Pinar del Río.[abstract].      Rev Cubana Endocrinol 1997;8(1):75.</span><span     style='mso-bidi-font-size:12.0pt'><o:p></o:p></span></li><li class=MsoNormal style='mso-list:l1 level1 lfo5;tab-stops:list 36.0pt'><span     style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";     mso-bidi-font-weight:bold'>Rivero H, </span><span lang=ES-MX     style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";     mso-ansi-language:ES-MX;mso-bidi-font-weight:bold'>Uz ME de la</span><span     style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";     mso-bidi-font-weight:bold'>, Matos T, Trujillo L. Comportamiento de la diabetes      ]]></body>
<body><![CDATA[mellitus en el área de salud urbana de “Isabel Rubio”, Guane</span><span     lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:     "CG Times";mso-ansi-language:ES-MX;mso-bidi-font-weight:bold'>. [abstract].      Rev Cubana Endocrinol 1997;8(1):75.</span><span     style='mso-bidi-font-size:12.0pt'><o:p></o:p></span></li><li class=MsoNormal style='mso-list:l1 level1 lfo5;tab-stops:list 36.0pt'><span     lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:     "CG Times";mso-ansi-language:ES-MX;mso-bidi-font-weight:bold'>García R, Suárez      R, Peralta R. Diagnóstico educativo sobre la enfermedad en pacientes diabéticos      de la tercera edad. Rev Cubana Endocrinol 1996;7(1):15-25.</span><span style='mso-bidi-font-size:12.0pt'><o:p></o:p></span></li><li class=MsoNormal style='mso-list:l1 level1 lfo5;tab-stops:list 36.0pt'><span     lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:     ]]></body>
<body><![CDATA["CG Times";mso-ansi-language:ES-MX;mso-bidi-font-weight:bold'>Navarro D,      Faget O, Leonard R. Características de la diabetes mellitus en el anciano. Rev      Cubana Med Gen Integr 1993;9(1):9-14.</span><span style='mso-bidi-font-size:     12.0pt'><o:p></o:p></span></li><li class=MsoNormal style='mso-list:l1 level1 lfo5;tab-stops:list 36.0pt'><span     lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:     "CG Times";mso-ansi-language:ES-MX;mso-bidi-font-weight:bold'>Crespo JL,      Bustillo E, Pérez R, Bustillo I. Beneficios del ejercicio físico sistemático en      pacientes diabéticos no insulinodependientes. Rev Cubana Endocrinol 1994;5(1):46-51.</span><span style='mso-bidi-font-size:12.0pt'><o:p></o:p></span></li><li class=MsoNormal style='mso-list:l1 level1 lfo5;tab-stops:list 36.0pt'><span     lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:     "CG Times";mso-ansi-language:ES-MX;mso-bidi-font-weight:bold'>Valenciaga      ]]></body>
<body><![CDATA[R, González F, Pons P, Sánchez O. Repercusión en el control de la diabetes mellitus      de una técnica educativa dirigida a la familia. Rev Cubana Med Gen Integr 1995;11(2):144-9.</span><span style='mso-bidi-font-size:12.0pt'><o:p></o:p></span></li><li class=MsoNormal style='mso-list:l1 level1 lfo5;tab-stops:list 36.0pt'><span     lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:     "CG Times";mso-ansi-language:ES-MX;mso-bidi-font-weight:bold'>Carrasco MR,      Hernández G, Rodríguez MM, Santos D, González S. Diabetes mellitus asociada con      enfermedades crónicas en el anciano. </span><span lang=EN-US     style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";     mso-ansi-language:EN-US;mso-bidi-font-weight:bold'>Rev Cubana Med Gen Integr      1992;8(1):38-42.</span><span lang=EN-US style='mso-bidi-font-size:     12.0pt;mso-ansi-language:EN-US'><o:p></o:p></span></li><li class=MsoNormal style='mso-list:l1 level1 lfo5;tab-stops:list 36.0pt'><span     ]]></body>
<body><![CDATA[lang=EN-US style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:     "CG Times";mso-ansi-language:EN-US;mso-bidi-font-weight:bold'>Kannel WB,      McGee DL. Diabetes and cardiovascular disease: the Framingham study. J Am Med      Assoc 1979;241:2035-8</span><span lang=EN-US style='mso-bidi-font-size:     12.0pt;mso-ansi-language:EN-US'><o:p></o:p></span></li><li class=MsoNormal style='mso-list:l1 level1 lfo5;tab-stops:list 36.0pt'><span     lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:     "CG Times";mso-ansi-language:ES-MX;mso-bidi-font-weight:bold'>Comisión Nacional      de Hipertensión Arterial. Programa Nacional de Prevención, Diagnóstico, Evaluación      y Control de la Hipertensión Arterial. Rev Cubana Med 1999;38(3):160-9.</span><span style='mso-bidi-font-size:12.0pt'><o:p></o:p></span></li><li class=MsoNormal style='mso-list:l1 level1 lfo5;tab-stops:list 36.0pt'><span     lang=EN-US style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:     ]]></body>
<body><![CDATA["CG Times";mso-ansi-language:EN-US;mso-bidi-font-weight:bold'>Kopelman PG.      Investigation of obesity. Clin Endocrinol 1994;41:703-8.</span><span     lang=EN-US style='mso-bidi-font-size:12.0pt;mso-ansi-language:EN-US'><o:p></o:p></span></li><li class=MsoNormal style='mso-list:l1 level1 lfo5;tab-stops:list 36.0pt'><span     lang=EN-US style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:     "CG Times";mso-ansi-language:EN-US;mso-bidi-font-weight:bold'>Hodge AM, Zimmet      PZ. The epidemiology of obesity. Bailliere´s Clinical Endocrinol Metab 1994;8(3):577-99.</span><span lang=EN-US style='mso-bidi-font-size:     12.0pt;mso-ansi-language:EN-US'><o:p></o:p></span></li><li class=MsoNormal style='mso-list:l1 level1 lfo5;tab-stops:list 36.0pt'><span     lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:     "CG Times";mso-ansi-language:ES-MX;mso-bidi-font-weight:bold'>Martínez-Valls      JF. Fisiopatología y tratamiento de la obesidad. </span><span lang=EN-US     ]]></body>
<body><![CDATA[style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times";     mso-ansi-language:EN-US;mso-bidi-font-weight:bold'>Medicine 1993;6(36):1549-60.</span><span lang=EN-US style='mso-bidi-font-size:12.0pt;     mso-ansi-language:EN-US'><o:p></o:p></span></li><li class=MsoNormal style='mso-list:l1 level1 lfo5;tab-stops:list 36.0pt'><span     lang=EN-US style='mso-bidi-font-size:12.0pt;mso-ansi-language:EN-US'>Screning      for obesity. In: US Preventive Task Force: Guide to Clinical Preventive Services,      Report of the US Preventive Services Task Force. Baltimore: Williams &amp; Wilkins;      1996.<o:p></o:p></span></li>    </ol>    <p class=MsoNormal style='text-align:justify'><span lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times"; mso-ansi-language:ES-MX;mso-bidi-font-weight:bold'>Recibido: 5 de septiembre de  2003.<span style="mso-spacerun: yes">  </span>Aprobado: 20 de noviembre de 2003.</span></p>    <p class=MsoBodyText><span lang=ES-MX style='font-size:11.0pt;mso-bidi-font-size: 10.0pt;font-family:"CG Times";mso-bidi-font-weight:bold'>Dr. <i>Mayque Guzmán</i>.  Hospital General “Ciro Redondo García”. Carretera Central km 59 ½, Artemisa, CP  33800. La Habana. Teléf: 36 30 11.</span></p></div>      ]]></body>
<body><![CDATA[ ]]></body><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<article-title xml:lang="es"><![CDATA[Declaración de las Américas sobre la Diabetes]]></article-title>
<source><![CDATA[Panam Health Org Bull]]></source>
<year>1996</year>
<volume>30</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>261-5</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gordon]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Gill]]></surname>
<given-names><![CDATA[MD]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Diabetes mellitus]]></article-title>
<source><![CDATA[Tratado de Medicina Interna II]]></source>
<year>1996</year>
<page-range>1449-73</page-range><publisher-loc><![CDATA[La Habana ]]></publisher-loc>
<publisher-name><![CDATA[Editorial Ciencias Médicas]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nathan]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Long-term complications of diabetes mellitus]]></article-title>
<source><![CDATA[N Eng J Med]]></source>
<year>1993</year>
<volume>328</volume>
<page-range>1676-85</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ochi]]></surname>
<given-names><![CDATA[JW]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[A population based study of diabetic mortality]]></article-title>
<source><![CDATA[Diabetes Care]]></source>
<year>1985</year>
<volume>8</volume>
<page-range>224-9</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tellería]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Jiménez]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Mayans]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Diabetes mellitus: Causas de muerte y hallazgos necrópsicos en el anciano]]></article-title>
<source><![CDATA[Rev Cubana Endocrinol]]></source>
<year>1994</year>
<volume>5</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>52-6</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Collado Mesa]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Vidal]]></surname>
<given-names><![CDATA[MG]]></given-names>
</name>
<name>
<surname><![CDATA[Durruty]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Sordo]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
<name>
<surname><![CDATA[Montero]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Diabetes mellitus como causa básica de muerte]]></article-title>
<source><![CDATA[Rev Cubana Endocrinol]]></source>
<year>1998</year>
<volume>9</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>184-93</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Flores]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Bell]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Diabetes mellitus e hipertensión arterial]]></article-title>
<source><![CDATA[Acta Médica]]></source>
<year>1997</year>
<volume>7</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>122-32</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sowers]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
<name>
<surname><![CDATA[Zemel]]></surname>
<given-names><![CDATA[MB]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Clinical implications of hypertension in the diabetic patient: a review]]></article-title>
<source><![CDATA[Am J Hypertens]]></source>
<year>1990</year>
<volume>3</volume>
<page-range>415-24</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Roman]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Guanche]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Molina]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Morcolella]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Factores asociados a la presencia de cardiopatía isquémica en diabéticos]]></article-title>
<source><![CDATA[. Rev Cubana Endocrinol]]></source>
<year>1997</year>
<volume>8</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>88</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Keen]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Microalbuminuria: marker of risk of diabetes complications]]></article-title>
<source><![CDATA[Care Elder]]></source>
<year>1993</year>
<volume>5</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>338-402</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Batista]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
<name>
<surname><![CDATA[Licea]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Enfermedad muscular cardíaca diabética]]></article-title>
<source><![CDATA[Rev Cubana Endocrinol]]></source>
<year>1998</year>
<volume>9</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>132-48</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lang]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Licea]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Borges]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Revilla]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Reina]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[La diabetes mellitus y su relación con la enfermedad cerebrovascular: estudio de 265 pacientes]]></article-title>
<source><![CDATA[Rev Cubana Endocrinol]]></source>
<year>1992</year>
<volume>3</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>122-32</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Faget]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández Yero]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Licea]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Perich]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Seuc]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Caracterización clínica de los diabéticos con ingreso ambulatorio]]></article-title>
<source><![CDATA[Rev Cubana Endocrinol]]></source>
<year>1994</year>
<volume>5</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>81-9</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jiménez]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Tellería]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Sigler]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Mayans]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Algunos aspectos clínicoepidemiológicos de la diabetes mellitus en el municipio Morón]]></article-title>
<source><![CDATA[. Rev Cubana Endocrinol]]></source>
<year>1997</year>
<volume>8</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>73</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lozano]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Caracterización clínica de la diabetes mellitus en 150 pacientes de 15 años y más de edad]]></article-title>
<source><![CDATA[. Rev Cubana Endocrinol]]></source>
<year>1997</year>
<volume>8</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>74</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rivero]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Uz]]></surname>
<given-names><![CDATA[ME de la]]></given-names>
</name>
<name>
<surname><![CDATA[Matos]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Trujillo]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Comportamiento de la diabetes mellitus en un grupo de consultorios de área del policlínico “Hermanos Cruz” del municipio Pinar del Río]]></article-title>
<source><![CDATA[Rev Cubana Endocrinol]]></source>
<year>1997</year>
<volume>8</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>74</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rivero]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Uz]]></surname>
<given-names><![CDATA[ME de la]]></given-names>
</name>
<name>
<surname><![CDATA[Matos]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Trujillo]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Comportamiento de la diabetes mellitus en el período de 1991 a 1994 en el centro de atención al diabético de Pinar del Río]]></article-title>
<source><![CDATA[Rev Cubana Endocrinol]]></source>
<year>1997</year>
<volume>8</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>75</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rivero]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Uz]]></surname>
<given-names><![CDATA[ME de la]]></given-names>
</name>
<name>
<surname><![CDATA[Matos]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Trujillo]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Comportamiento de la diabetes mellitus en el área de salud urbana de “Isabel Rubio”, Guane]]></article-title>
<source><![CDATA[Rev Cubana Endocrinol]]></source>
<year>1997</year>
<volume>8</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>75</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Suárez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Peralta]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Diagnóstico educativo sobre la enfermedad en pacientes diabéticos de la tercera edad]]></article-title>
<source><![CDATA[Rev Cubana Endocrinol]]></source>
<year>1996</year>
<volume>7</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>15-25</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Navarro]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Faget]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Leonard]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Características de la diabetes mellitus en el anciano]]></article-title>
<source><![CDATA[Rev Cubana Med Gen Integr]]></source>
<year>1993</year>
<volume>9</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>9-14</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Crespo]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Bustillo]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Bustillo]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Beneficios del ejercicio físico sistemático en pacientes diabéticos no insulinodependientes]]></article-title>
<source><![CDATA[Rev Cubana Endocrinol]]></source>
<year>1994</year>
<volume>5</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>46-51</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Valenciaga]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Pons]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Repercusión en el control de la diabetes mellitus de una técnica educativa dirigida a la familia]]></article-title>
<source><![CDATA[Rev Cubana Med Gen Integr]]></source>
<year>1995</year>
<volume>11</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>144-9</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carrasco]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Santos]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Diabetes mellitus asociada con enfermedades crónicas en el anciano]]></article-title>
<source><![CDATA[Rev Cubana Med Gen Integr]]></source>
<year>1992</year>
<volume>8</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>38-42</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kannel]]></surname>
<given-names><![CDATA[WB]]></given-names>
</name>
<name>
<surname><![CDATA[McGee]]></surname>
<given-names><![CDATA[DL]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Diabetes and cardiovascular disease: the Framingham study]]></article-title>
<source><![CDATA[J Am Med Assoc]]></source>
<year>1979</year>
<volume>241</volume>
<page-range>2035-8</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<collab>Comisión Nacional de Hipertensión Arterial</collab>
<article-title xml:lang="es"><![CDATA[Programa Nacional de Prevención, Diagnóstico, Evaluación y Control de la Hipertensión Arterial]]></article-title>
<source><![CDATA[Rev Cubana Med]]></source>
<year>1999</year>
<volume>38</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>160-9</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kopelman]]></surname>
<given-names><![CDATA[PG]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Investigation of obesity]]></article-title>
<source><![CDATA[Clin Endocrinol]]></source>
<year>1994</year>
<volume>41</volume>
<page-range>703-8</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hodge]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Zimmet]]></surname>
<given-names><![CDATA[PZ]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[The epidemiology of obesity]]></article-title>
<source><![CDATA[Bailliere´s Clinical Endocrinol Metab]]></source>
<year>1994</year>
<volume>8</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>577-99</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martínez-Valls]]></surname>
<given-names><![CDATA[JF]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Fisiopatología y tratamiento de la obesidad]]></article-title>
<source><![CDATA[Medicine]]></source>
<year>1993</year>
<volume>6</volume>
<numero>36</numero>
<issue>36</issue>
<page-range>1549-60</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="book">
<article-title xml:lang="en"><![CDATA[Screning for obesity]]></article-title>
<source><![CDATA[US Preventive Task Force: Guide to Clinical Preventive Services, Report of the US Preventive Services Task Force]]></source>
<year>1996</year>
<publisher-loc><![CDATA[Baltimore ]]></publisher-loc>
<publisher-name><![CDATA[Williams & Wilkins]]></publisher-name>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
